Veradigm Gross Profit 2010-2022 | MDRX
Veradigm gross profit from 2010 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Veradigm Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2022 | $308 |
| 2021 | $282 |
| 2020 | $264 |
| 2019 | $610 |
| 2018 | $621 |
| 2017 | $633 |
| 2016 | $601 |
| 2015 | $581 |
| 2014 | $546 |
| 2013 | $534 |
| 2012 | $607 |
| 2011 | $666 |
| 2010 | $298 |
| 2010 | $389 |
| 2009 | $292 |
| Veradigm Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2022-12-31 | $72 |
| 2022-09-30 | $83 |
| 2022-06-30 | $79 |
| 2022-03-31 | $73 |
| 2021-12-31 | $81 |
| 2021-09-30 | $70 |
| 2021-06-30 | $68 |
| 2021-03-31 | $63 |
| 2020-12-31 | $-140 |
| 2020-09-30 | $135 |
| 2020-06-30 | $138 |
| 2020-03-31 | $132 |
| 2019-12-31 | $77 |
| 2019-09-30 | $175 |
| 2019-06-30 | $184 |
| 2019-03-31 | $174 |
| 2018-12-31 | $85 |
| 2018-09-30 | $178 |
| 2018-06-30 | $174 |
| 2018-03-31 | $185 |
| 2017-12-31 | $65 |
| 2017-09-30 | $202 |
| 2017-06-30 | $187 |
| 2017-03-31 | $179 |
| 2016-12-31 | $117 |
| 2016-09-30 | $166 |
| 2016-06-30 | $167 |
| 2016-03-31 | $152 |
| 2015-12-31 | $154 |
| 2015-09-30 | $153 |
| 2015-06-30 | $144 |
| 2015-03-31 | $130 |
| 2014-12-31 | $136 |
| 2014-09-30 | $131 |
| 2014-06-30 | $140 |
| 2014-03-31 | $138 |
| 2013-12-31 | $138 |
| 2013-09-30 | $126 |
| 2013-06-30 | $136 |
| 2013-03-31 | $134 |
| 2012-12-31 | $136 |
| 2012-09-30 | $157 |
| 2012-06-30 | $157 |
| 2012-03-31 | $156 |
| 2011-12-31 | $176 |
| 2011-09-30 | $162 |
| 2011-06-30 | $168 |
| 2011-03-31 | $160 |
| 2010-12-31 | $146 |
| 2010-09-30 | $124 |
| 2010-06-30 | $105 |
| 2010-05-31 | |
| 2010-03-31 | $104 |
| 2010-02-28 | $102 |
| 2009-12-31 | |
| 2009-11-30 | $96 |
| 2009-09-30 | $89 |
| 2009-08-31 | $89 |
| 2009-05-31 | |
| 2009-02-28 | $83 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.466B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.567B | 53.27 |
| Hims & Hers Health (HIMS) | United States | $11.630B | 120.84 |
| Tempus AI (TEM) | United States | $10.569B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.461B | 69.70 |
| IRhythm Technologies (IRTC) | United States | $4.396B | 0.00 |
| Privia Health (PRVA) | United States | $3.050B | 208.50 |
| Enovis (ENOV) | United States | $1.888B | 10.52 |
| Clover Health Investments (CLOV) | United States | $1.793B | 0.00 |
| Schrodinger (SDGR) | United States | $1.746B | 0.00 |
| Phreesia (PHR) | United States | $1.506B | 0.00 |
| Azenta (AZTA) | United States | $1.223B | 56.96 |
| Omnicell (OMCL) | United States | $1.208B | 21.31 |
| 10x Genomics (TXG) | United States | $1.073B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.600B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.509B | 151.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.371B | 827.00 |
| Claritev (CTEV) | United States | $0.351B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.290B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.107B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.089B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.088B | 0.00 |
| CareCloud (CCLD) | United States | $0.081B | 3.07 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |